MARKET

CDXS

CDXS

Codexis Inc
NASDAQ
4.100
-0.020
-0.49%
After Hours: 4.100 0 0.00% 19:47 02/13 EST
OPEN
4.220
PREV CLOSE
4.120
HIGH
4.240
LOW
4.035
VOLUME
413.75K
TURNOVER
--
52 WEEK HIGH
6.08
52 WEEK LOW
2.560
MARKET CAP
333.65M
P/E (TTM)
-4.6697
1D
5D
1M
3M
1Y
5Y
1D
Codexis to Report Fourth Quarter and Fiscal Year 2024 Financial Results on February 27th
Barchart · 9h ago
Alkermes (ALKS) Q4 Earnings and Revenues Surpass Estimates
NASDAQ · 1d ago
Weekly Report: what happened at CDXS last week (0203-0207)?
Weekly Report · 3d ago
CODEXIS APPOINTS ARTHUR LEVIN, PHD, TO STRATEGIC ADVISORY BOARD
Reuters · 02/06 21:05
Press Release: Codexis Appoints Arthur Levin, PhD, to Strategic Advisory Board
Dow Jones · 02/06 21:05
Weekly Report: what happened at CDXS last week (0127-0131)?
Weekly Report · 02/03 09:19
Institutional investors in Codexis, Inc. (NASDAQ:CDXS) see US$59m decrease in market cap last week, although long-term gains have benefitted them.
Simply Wall St · 02/01 13:07
Insider Purchase: 10% owner at $CDXS Buys 45,000 Shares
NASDAQ · 02/01 00:15
More
About CDXS
Codexis, Inc. is an enzyme engineering company. It is leveraging its CodeEvolver technology platform to discover, develop, enhance, and commercialize novel, high performance enzymes and other classes of proteins. It utilizes its CodeEvolver technology platform to develop optimized enzymes that are used by some pharmaceutical companies to reduce their costs and improve the efficiency and productivity of their manufacturing processes for small molecule therapeutics. It is developing its Enzyme-Catalyzed Oligonucleotide Synthesis (ECO Synthesis) manufacturing platform to enable the scaled manufacture of RNA interference (RNAi) therapeutics through an enzymatic route. It also uses the CodeEvolver platform technology to develop enzymes for the synthesis of nucleic acids, such as DNA/RNA, including enzymes utilized in its ECO Synthesis manufacturing platform, where its enzymes are poised to deliver many of the same benefits it offers in pharmaceutical manufacturing.

Webull offers Codexis Inc stock information, including NASDAQ: CDXS real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, CDXS stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading CDXS stock methods without spending real money on the virtual paper trading platform.